BG International Pharma Consulting SRL
BG International Pharma Consulting reported total assets of 359,124 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Aug 2026).
By total assets for 2025, BG International Pharma Consulting ranks among the 2,000 largest of the 6,145 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of BG International Pharma Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +222 % Total assets +40 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BG International Pharma Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 103,821 € | ||||
| Equity | 242,936 € | ||||
| Cash | 40,645 € | ||||
| EBITDA | 142,640 € | ||||
| Total assets | 359,124 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Aug 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 01 Sep 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
BG International Pharma Consulting's financial analysis
- Solvency67.6%sector median: 52.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BG International Pharma Consulting
1 active director(s) in the register.
BG International Pharma Consulting's shareholders and holdings →BG International Pharma Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0765.640.202
- VAT number
- BE0765640202
- Peppol
- Registered · 0208:0765640202 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 25 Mar 2021
- Registered office
- 1470 Genappe
- Latest accounts
- 2025 · filed on 30 Aug 2026
- Activity
- Public relations and communication activities (NACE 73300)
BG International Pharma Consulting (SRL) has been based in Genappe since 2021, active in: public relations and communication activities. For 2025, it reports a net profit of 103,821 € and equity of 242,936 €; its revenue is not published. Its solvency stands at 67.6%, above the median of its sector (52.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BG International Pharma Consulting
Companies in the same business, of comparable size and area, outside its group.
- BE.AM Projects Public relations and communication activities Deinze · balance sheet 352,920 €
- TVD-Consulting Public relations and communication activities Destelbergen · balance sheet 437,000 €
- Bureau 240 Public relations and communication activities Ixelles · balance sheet 59,944 €
- Shift Networks Public relations and communication activities Zandhoven · balance sheet 143,438 €
- IT-as-a-Service Consulting Public relations and communication activities Rixensart · balance sheet 368,567 €
- OPT-in Public relations and communication activities Ath · balance sheet 404,578 €
- Station Growth Public relations and communication activities Woluwe-Saint-Pierre · balance sheet 326,615 €
- Piëzo Consulting Public relations and communication activities Zemst · balance sheet 299,387 €
Frequently asked questions about BG International Pharma Consulting
What is the revenue of BG International Pharma Consulting?
BG International Pharma Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BG International Pharma Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0765640202 for BG International Pharma Consulting, if the company is VAT-registered. Its company number (CBE) is 0765.640.202.
Where is the registered office of BG International Pharma Consulting?
According to the CBE register, the registered office of BG International Pharma Consulting is in 1470 Genappe.
What is the equity of BG International Pharma Consulting?
At the close of the 2025 financial year, the equity of BG International Pharma Consulting amounts to 242,936 €, a solvency of 67.6% of total assets.
Who manages BG International Pharma Consulting?
The register lists 1 active mandates at BG International Pharma Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is BG International Pharma Consulting within its sector?
By total assets for 2025, BG International Pharma Consulting ranks among the 2,000 largest of the 6,145 companies in its sector (NACE 7330) in Belgium that filed accounts for that financial year.
The full file of BG International Pharma Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →